GFPC
NVO

Global Financial Private Client’s Novo Nordisk NVO Stock Holding History

Global Financial Private Client’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-168
Closed -$11.7K – 1143
2025
Q1 		$11.7K Hold
168
– – ﹤0.01% 551
2024
Q4 		$14.5K Hold
168
– – 0.01% 480
2024
Q3 		$20K Buy
+168
New +$22.4K 0.01% 432

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Global Financial Private Client's NVO Position: Q2 2025 in Review

Global Financial Private Client sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 168 shares — an estimated $11.7K sold.

Global Financial Private Client first reported a position in NVO in Q3 2024 and held it in 3 quarters. The position peaked at $20K in Q3 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Global Financial Private Client reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Global Financial Private Client sold 168 Novo Nordisk shares in Q2 2025, an estimated $11.7K.
  • Global Financial Private Client first reported a position in Novo Nordisk in Q3 2024 and held it in 3 quarters.
  • Global Financial Private Client's Novo Nordisk position peaked at $20K in Q3 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.